miR‑148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑G expression

Zhang,Yuying; Jin,Xin; Wang,Jie

doi:10.3892/mmr.2019.10280

miR‑148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑G expression

Authors:
- Yuying Zhang
- Xin Jin
- Jie Wang
View Affiliations

Affiliations: Department of Stomatology, The First People's Hospital of Jining, Jining, Shandong 272100, P.R. China
Published online on: May 22, 2019 https://doi.org/10.3892/mmr.2019.10280
Pages: 795-801
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral squamous cell carcinoma (OSCC) is a common malignancy of the oral and maxillofacial regions. MicroRNAs (miRs) are a group of endogenous small noncoding RNAs that inhibit gene expression by binding to the mRNA of target genes, and serve important roles in numerous biological processes. Reverse transcription‑quantitative polymerase chain reaction and western blotting were used to detect gene and protein expression levels, respectively. Cell proliferation, migration and invasion were detected using MTT, wound healing and Matrigel assays, respectively. The association between miR‑148a and human leukocyte antigen‑G (HLA‑G) was analyzed using Targetscan and Luciferase reporter assays. In the present study, miR‑148a was revealed to be significantly downregulated in OSCC cells. To further investigate the functions of miR‑148a in OSCC, the viability, migration, and invasive abilities of SCC‑9 cells were investigated following transfection with miR‑148a mimics or miR‑148a inhibitor. It was revealed that transfection with miR‑148a mimics significantly reduced the viability, migration and invasion of cells, whereas miR‑148a inhibitor significantly enhanced these properties. In addition, HLA‑G was identified as a direct target of miR‑148a and demonstrated to be downregulated in OSCC cells. Furthermore, it was revealed that transfection with miR‑148a mimics decreased the expression levels of HLA‑G mRNA and protein in SCC‑9 cells, whereas transfection with miR‑148a inhibitor increased the expression of HLA‑G mRNA and protein. The results indicated that there was an association between miR‑148a and HLA‑G expression, and suggested that miR‑148a may be a potential target in the treatment of OSCC.

View Figures

View References

1	Tang H, Wu Z, Zhang J and Su B: Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 7:761–766. 2013. View Article : Google Scholar : PubMed/NCBI
2	Zhao E, Xu J, Yin X, Sun Y, Shi J and Li X: Detection of deregulated pathways to lymphatic metastasis in oral squamous cell carcinoma. Pathol Oncol Res. 15:217–223. 2009. View Article : Google Scholar : PubMed/NCBI
3	Singh P, Barpande SR, Bhavthankar JD, Mandale MS and Bhagwat AU: Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation. Indian J Dent Res. 28:162–168. 2017. View Article : Google Scholar : PubMed/NCBI
4	Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, et al: Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2:92010. View Article : Google Scholar : PubMed/NCBI
5	Rich A, Hussaini H, Parachuru P and Seymour G: The tumour microenvironment in oral squamous cell carcinoma. Pathology. 46 (Suppl 1):S92014. View Article : Google Scholar
6	Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H, Toida M and Shibata T: Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: Manifestation and localization of their activity. J Cancer Res Clin Oncol. 131:340–346. 2005. View Article : Google Scholar : PubMed/NCBI
7	Shahrabi S, Hadad EH, Asnafi AA, Behzad MM, Ehsanpour A and Saki N: Human leukocyte antigens in cancer metastasis: Prognostic approach and therapeutic susceptibility. Histol Histopathol. 34:111–124. 2019.PubMed/NCBI
8	Alizadeh N, Mosaferi E, Farzadi L, Majidi J, Monfaredan A, Yousefi B and Baradaran B: Frequency of null allele of human leukocyte antigen-G (HLA-G) locus in subjects to recurrent miscarriage. Int J Reprod Biomed (Yazd). 14:459–464. 2016. View Article : Google Scholar : PubMed/NCBI
9	Yie SM, Li LH, Xiao R and Librach CL: A single base-pair mutation in the 3′-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod. 14:649–653. 2008. View Article : Google Scholar : PubMed/NCBI
10	Ferreira LM, Meissner TB, Tilburgs T and Strominger JL: HLA-G: At the interface of maternal-fetal tolerance. Trends Immunol. 38:272–286. 2017. View Article : Google Scholar : PubMed/NCBI
11	Bian X, Si Y, Zhang M, Wei R, Yang X, Ren H, Zheng G, Wang C and Zhang Y: Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G. Tumour Biol. 37:3749–3756. 2016. View Article : Google Scholar : PubMed/NCBI
12	Costa CH, Gelmini GF, Nardi FS, Roxo VM, Schuffner A and da Graça Bicalho M: HLA-G profile of infertile couples who underwent assisted reproduction treatment. Hum Immunol. 77:1179–1186. 2016. View Article : Google Scholar : PubMed/NCBI
13	Lazarte J, Adamson MB, Tumiati LC and Delgado DH: 10-year experience with HLA-G in heart transplantation. Hum Immunol. 79:587–593. 2018. View Article : Google Scholar : PubMed/NCBI
14	Beneventi F, Badulli C, Locatelli E, Caporali R, Ramoni V, Cavagnoli C, Simonetta M, Garbin G, Tinelli C, Alpini C, et al: Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases. J Reprod Immunol. 110:67–73. 2015. View Article : Google Scholar : PubMed/NCBI
15	Seliger B: Role of microRNAs on HLA-G expression in human tumors. Hum Immunol. 77:760–763. 2016. View Article : Google Scholar : PubMed/NCBI
16	Li X, Liu F, Lin B, Luo H, Liu M, Wu J, Li C, Li R, Zhang X, Zhou K and Ren D: miR-150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma. Int J Oncol. 50:1097–1108. 2017. View Article : Google Scholar :
17	Ro S, Park C, Young D, Sanders KM and Yan W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res. 35:5944–5953. 2007. View Article : Google Scholar : PubMed/NCBI
18	Mallory AC and Vaucheret H: MicroRNAs: Something important between the genes. Curr Opin Plant Biol. 7:120–125. 2004. View Article : Google Scholar : PubMed/NCBI
19	Garzon R, Calin GA and Croce CM: MicroRNAs in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
20	Zhou X, Zhao F, Wang ZN, Song YX, Chang H, Chiang Y and Xu HM: Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep. 27:447–454. 2012.PubMed/NCBI
21	Yang JS, Li BJ, Lu HW, Chen Y, Lu C, Zhu RX, Liu SH, Yi QT, Li J and Song CH: Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Tumour Biol. 36:3035–3042. 2015. View Article : Google Scholar : PubMed/NCBI
22	Chen Q, Luo G and Zhang X: MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. Exp Ther Med. 14:4448–4452. 2017.PubMed/NCBI
23	Sun J, Chu H, Ji J, Huo G, Song Q and Zhang X: Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer. Int J Oncol. 49:943–952. 2016. View Article : Google Scholar : PubMed/NCBI
24	Tao S, He H, Chen Q and Yeu W: GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer. Biochem Biophys Res Commun. 451:74–78. 2014. View Article : Google Scholar : PubMed/NCBI
25	Imani R, Seyedmajidi M, Ghasemi N, Moslemi D, Shafaee S and Bijani A: HLA-G expression is associated with an unfavorable prognosis of oral squamous cell carcinoma. Asian Pac J Cancer Prev. 19:2527–2533. 2018.PubMed/NCBI
26	Gonçalves AS, Wastowski IJ, Capeletti LR, Sacono NT, Cortez AP, Valadares MC, Silva TA and Batista AC: The clinicopathologic significance of the expression of HLA-G in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 117:361–368. 2014. View Article : Google Scholar : PubMed/NCBI
27	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
28	Cui Z, Liu G and Kong D: miRNA-27a promotes the proliferation and inhibits apoptosis of human pancreatic cancer cells by Wnt/β-catenin pathway. Oncol Rep. 39:755–763. 2018.PubMed/NCBI
29	Mo D, Yang D, Xiao X, Sun R, Huang L and Xu J: MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin. Biotechnol Lett. 39:701–710. 2010. View Article : Google Scholar
30	Liu F, Zhang G, Lv S, Wen X and Liu P: miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis. J Cell Biochem. Mar 4–2019.(Epub ahead of print). doi: 10.1002/jcb.28528.
31	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
32	Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
33	Kent OA and Mendell JT: A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
34	Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, Lui MT and Lin SC: Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol. 49:27–33. 2013. View Article : Google Scholar : PubMed/NCBI
35	Chawla JP, Iyer N, Soodan KS, Sharma A, Khurana SK and Priyadarshni P: Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer. Oral Oncol. 51:731–737. 2015. View Article : Google Scholar : PubMed/NCBI
36	Ren Y, Zhu H, Chi C, Yang F and Xu X: MiRNA-139 regulates oral cancer Tca8113 cells apoptosis through Akt signaling pathway. Int J Clin Exp Pathol. 8:4588–4594. 2015.PubMed/NCBI
37	Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T and Hu F: miR-195 is a key regulator of Raf1 in thyroid cancer. Onco Targets Ther. 8:3021–3028. 2015. View Article : Google Scholar : PubMed/NCBI
38	Wang M, Zhang J, Tong L, Ma X and Qiu X: MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. Int J Clin Exp Pathol. 8:14110–14120. 2015.PubMed/NCBI
39	Yilaz Susluer S, Biray Avci C, Dodurga Y, Ozlem Dogan Sigva Z, Oktar N and Gunduz C: Downregulation of miR-195 via cyclosporin A in human glioblastoma cells. J BUON. 20:1337–1340. 2015.PubMed/NCBI
40	Li L, Li C, Wang S, Wang Z, Jiang J, Wang W, Li X, Chen J, Liu K, Li C and Zhu G: Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 76:1770–1780. 2016. View Article : Google Scholar : PubMed/NCBI
41	He S, Lai R, Chen D, Yan W, Zhang Z, Liu Z, Ding X and Chen Y: Downregulation of miR-221 inhibits cell migration and invasion through targeting methyl-CpG binding domain protein 2 in human oral squamous cell carcinoma cells. Biomed Res Int. 2015:7516722015. View Article : Google Scholar : PubMed/NCBI
42	Cheng CM, Shiah SG, Huang CC, Hsiao JR and Chang JY: Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. J Pathol. 240:38–49. 2016. View Article : Google Scholar : PubMed/NCBI
43	Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng H and Lai M: MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ. 18:1702–1710. 2011. View Article : Google Scholar : PubMed/NCBI
44	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
45	Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
46	Liu H, Liu X, Jin H, Yang F, Gu W and Li X: Proteomic analysis of knock-down HLA-G in invasion of human trophoblast cell line JEG-3. Int J Clin Exp Pathol. 6:2451–2459. 2013.PubMed/NCBI
47	Rouas-Freiss N, Moreau P, Ferrone S and Carosella ED: HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism? Cancer Res. 65:10139–10144. 2005. View Article : Google Scholar : PubMed/NCBI
48	Tripathi P and Agrawal S: Non-classical HLA-G antigen and its role in the cancer progression. Cancer Invest. 24:178–186. 2006. View Article : Google Scholar : PubMed/NCBI